Similar articles

• [Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report].

  Sai S, Sakakibara T, Takashi M, Sakata T, Miyake K. Sai S, et al. Hinyokika Kiyo. 1990 Aug;36(8):953-5. Hinyokika Kiyo. 1990. PMID: 2239600 Japanese.
• BCG in bladder cancer.

  Meek D. Meek D. Nurs Times. 1994 Oct 26-Nov 1;90(43):34-5. Nurs Times. 1994. PMID: 7984457
• Multicenter study of the BCG Tokyo strain for intravesical treatment in patients with superficial bladder cancer. BCG Study Group.

  Aso Y, Akaza H, Kameyama S, Niijima T. Aso Y, et al. Prog Clin Biol Res. 1989;303:383-91. Prog Clin Biol Res. 1989. PMID: 2675000 Clinical Trial. No abstract available.
• New approaches to intravesical chemo-immunotherapy in superficial bladder cancer.

  van der Meijden AP. van der Meijden AP. Prog Clin Biol Res. 1992;378:95-101. Prog Clin Biol Res. 1992. PMID: 1301591 Review. No abstract available.
• [Preventive treatment of superficial tumors of the bladder using intravesical BCG. Review].

  Patard JJ, Chopin DK. Patard JJ, et al. Ann Urol (Paris). 1993;27(1):24-30. Ann Urol (Paris). 1993. PMID: 8470876 Review. French.